The NANOSPONGES: AN INNOVATIVE DRUG DELIVERY SYSTEM
NANOSPONGES: AN INNOVATIVE DRUG DELIVERY SYSTEM
For prolonged time there is a delusion for efficacious targeted drug delivery system, but the chemistry hold complex form had made situations thorny, but the development of new colloidal carrier called nanosponges (NSs) likely circumvent these problems. NSs are the nanoporous particles that can entangle a huge range of material and then be engulfed into a suitable formulation depend on the route of administration. They prevent the drug-protein degradation, lengthen the drug release in a controlled manner, and release the medicament to the target site. They can travel around the body and attach on the surface and liberate the drug in a controlled and predictable manner at the specific target site. They are fine aqueous solubility which makes them a bearer for low water-soluble drugs. Drugs having low bioavailability are best suited for this type of carrier system. Both lipophilic and hydrophilic drugs can be included in NSs. Particle size can change from smaller to bigger by varying the amount of crosslinker to the polymer. Various applications of NSs such as recovering bioavailability of active ingredient molecule and delivery of active ingredient into oral, topical, parenteral, and nasal route make them a superior candidate for targeted delivery of drugs. It can be used as a shipper for biocatalysts in the transport and release of enzymes, proteins, vaccines, and antibodies. They can be prepared by different methods such as emulsion solvent diffusion method, melt method, ultrasound-assisted method, Quasi emulsion solvent diffusion method. This analysis is focusing on the advantages, formulation, evaluation, application, and patent report of the NSs.
2. Vyas SP, Khar RK. Novel Carrier Systems. Targeted and Controlled Drug Delivery. 1st ed. New Delhi: CBS Publishers; 2002. p. 332-13.
3. Chien YW. Novel Drug Delivery System, Drugs and the Pharmaceutical Sciences. Vol. 50. New York: Marcel Dekker Inc.; 2008. p. 797-2.
4. Pawar AY, Naik AK, Jadhav KR. Nanosponges: A novel drug delivery system. Asian J Pharm 2016 (Suppl);10:456-63.
5. Dhavala PB, Tenneti VS. An interesting nanosponges as a nanocarrier for novel drug delivery: A review. Int J Pharm Med Res 2017;5:1-7.
6. Bezawada S, Charanjitha, Reddy VM, Naveena. Nanosponges: A concise review for emerging trends. Int J Pharm Res Biomed Anal 2014;3:1-6.
7. Chilajwar SV, Pednekar PP, Jadhav KR, Gupta GJ, Kadam VJ. Cyclodextrin-based nanosponges: A propitious platform for enhancing drug delivery. Expert Opin Drug Deliv 2014;11:111-20.
8. Jyoti P, Tulsi B, Popin K, Chetna B. An innovative advancement for targeted drug delivery: Nanosponges. Indo Glob J Pharm Sci 2016;6:59 64.
9. Swaminathan S, Darandale S, Vavia PR. Nanosponge-aided drug delivery: A closer look. Pharm Formul Qual 2012;14:12-5.
10. Szejtli J. Cyclodextrin Technology. Berlin: Springer Science and Business Media; 1988. p. 450.
11. Trotta F, Tumiatti W, Inventors; Sea Marconi Technologies SAS assignee. Cross-Linked Polymers Based on Cyclodextrins for Removing Polluting Agents. WO/2003/085002. [Last accessed on 2003 Oct 16].
12. Trotta F, Cavalli R. Characterization and application of newhyper cross-linked cyclodextrins. Compos Interfaces 2009;16:39-48.
13. Salisbury D. Nanosponge Drug Delivery System more Effective Than Direct Injection. Nashville: Vanderbilt University; 2010. Available from: http://www.news.vanderbilt.edu/2010/06/nanosponge-drug-delivery-system-more-effective-thandirect-injection-116839. [Last accessed on 2012 Dec 20].
14. Subramanian S, Singireddy A, Krishnamoorthy K, Rajappan M. Nanosponges: A novel class of drug delivery system – review. J Pharm Pharm Sci 2012;15:103-11.
15. Alongi J, Poskovic M, Frache A, Trotta F. Role of ?-cyclodextrin nanosponges in polypropylene photooxidation. Carbohydr Polym 2011;86:127-35.
16. Singh D, Soni GC, Prajapati SK. Recent advances in nanosponges as drug delivery system: A review article. Eur J Pharm Med Res 2016;3:364-71.
17. Simranjot K, Sandeep K. Nanosponges: Present aspects and future challenges. Indo Am J Pharm Sci 2018;5:9390-8.
18. Tamkhane V, Sharma PH. Nanosponge – A novel drug delivery system. J Curr Pharm Res 2014;4:1186-93.
19. Liang L, Liu DP, Liang CC. Optimizing the delivery systems of chimeric RNA, DNA oligonucleotides beyond general oligonucleotide transfer. Eur J Biochem 2002;269:5753-8.
20. Jadhav PA, Jadhav SA. Review on: Nanosize delivery system. World J Pharm Pharm Sci 2017;6:433-44.
21. Vishwakarma A, Nikam P, Mogal R, Talele S. Review on nanosponges: A beneficiation for novel drug delivery. Int J PharmTech Res 2014;6:11 20.
22. Tiwari H, Mahor A, Dixit DN, Kushwaha M. A review on nanosponges. World J Pharm Pharm Sci 2014;3:219-33.
23. Bachkar AB, Gadhe TL, Battase P, Mahajan N, Wagh R, Talele S, et al. Nanosponges: A potential nanocarrier for targeted drug delivery. World J Pharm Res 2015;4:751-68.
24. Jilsha G, Viswanand V, Nanosponges: A novel approach of drug delivery system, Int J Pharm Sci Rev Res, 2013: 19; 119-23.
25. Bolmal UB, Manvi FV, Rajkumar K, Palla SS, Paladugu A, Reddy KR. Recent advances in nanosponges as a drug delivery system. Int J Pharm Sci Nanotechnol 2013;6:1934-44.
26. Subramanian S, Singireddy A, Krishnamoorthy K, Rajappan M. Nanosponges: A novel class of drug delivery system – review. J Pharm Pharm Sci 2012;15:103-11.
27. Osmani RA, Thirumaleshwar S, Bhosale RR, Kulkarni PK. Nanosponges: The spanking accession in drug delivery – An updated comprehensive review. Pelagia Res Lib Pharm Sin 2014;5:7-21.
28. Patel B, Bagade O, Ramteke K, Patel R, Awsarker V. An assessment on preparation, characterization and poles a part appliances of nanosponges. Int J PharmTech Res 2014;6:1898-907.
29. Jadhav PA, Jadhav SA. Review on: Nanosize delivery system. World J Pharm Pharm Sci 2017;6:433-44.
30. Bachkar BA, Gadhe LT, Battase P, Mahajan N, Wagh R, Talele S, et al. Nanosponges: A potential nanocarrier for targeted drug delivery. World J Pharm Res 2015;4:751-68.
31. Sharma R, Roderick B, Pathak K. Evaluation of kinetics and mechanism of drug release from econazole nitrate nanosponges loaded carbopol hydrogel. Indian J Pharm Educ Res 2011;45:25-31.
32. Embil K, Nacht S. Themicrosponge delivery system atopical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul 1996;13:575 88.
33. Jenny A, Merima P, Alberto F, Francesco T. Role of ?- cyclodextrin nanosponges in polypropylene photooxidation. Carbohydr Polym 2011;86:127-35.
34. Dhavala PB, Tenneti VS. An interesting nanosponges as a nanocarrier for novel drug delivery: A review. Int J Pharm Med Res 2017;5:1-7.
35. Shringirishi M, Prajapati SK, Mahor A, Alok S, Yadav P, Verma A. Nanosponges: A potential nanocarrier for novel drug delivery – A review. Asian Pac J Trop Dis 2014;4 Suppl 2:S519-26.
36. Cavalli R, Akhter AK, Bisazza A, Giustetto P, Trotta F, Vavia P. Nanosponge formulations as oxygen delivery systems. Int J Pharm 2010;402:254-7.
37. Lala R, Thorat A, Gargote C. Current trends in ?-cyclodextrin based drug delivery systems. Int J Res Ayurveda Pharm 2011;2:1520-6.
38. Salunkhe A, Kadam S, Magar S, Dangare K. Nanosponges: A modern formulation approach in drug delivery system. World J Pharm Pharm Sci 2015;7:575-92.
39. Rahi N, Kumar K. Nanosponges: A new era of versatile drug delivery system. Univ J Pharm 2017;2:31-5.
40. Trotta F, Cavalli R, Tumiatti W, Zerbinati O, Rogero C, Vallero R. Ultrasound-Assisted Synthesis of Cyclodextrin-Based Nanosponges. B1. European Patent Specification EP 1 786-41; 2007.
41. Rosalba M, Roberta C, Roberto F, Chiara D, Piergiorgio P, Leigh E, et al. Antitumor activity of nanosponge-encapsulated camptothecin in human prostate tumors. Cancer Res 2011;71:4431.
42. Renuka S, Roderick BW, Kamla P. Evaluation of the kinetics and mechanism of drug release from econazole nitrate nanosponge loaded carbapol hydrogel. Indian J Pharm Educ 2011;45:25-31.
43. Renuka S, Kamla P. Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol 2011;16:367-76.
44. Mamotra R, Bharti N, Bhandari N. Nanosponges as a potential carrier in novel drug delivery system. World J Pharm Pharm Sci 2016;5:415 24.
45. Targe BM, Patil MP, Jahagirdar AC, Khandekar BD. Nanosponges – An emerging drug delivery system. Int J Inst Pharm Life Sci 2015;5:160 74.
46. Malve NV, Gadhave MV, Banerjee SK, Gaikwad DD. Nanosponge: A novel approach in drug delivery system. Int J Pharm Life Sci 2014;4:2249-7.
47. Panda S, Vijayalakshmi SV, Pattnaik S, Swain RP. Nanosponges: A novel carrier for targeted drug delivery. Int J PharmTech Res 2015;8:213-24.
48. Waghmare GS, Nikhade RR, Kosalge SB. Nanosponges: Novel approach for controlled release drug delivery system. Int J Pharm Pharm Res 2017;9:102-16.
49. Ahmed RZ, Patil G, Zaheer Z. Nanosponges – A completely new nano-horizon: Pharmaceutical applications and recent advances. Drug Dev Ind Pharm 2013;39:1263-72.
50. Geeta Y, Hiten P. Nanosponges: A boon to the targeted drug delivery system. J Drug Deliv Ther 2013;3:151-5.
51. Tambe RS, Battase PW, Arane PM, Palve SA, Talele SG, Chaudhari G. Review on nanosponges: As a targeted drug delivery system. Am J Pharm Res 2015;5:216-24.
52. Shankar S, Vavia PR, Francesco T, Satyen T. Formulation of beta-cyclodextrin based nanosponges of itraconazole. J Incl Phenom Macrocyc Chem 2007;57:89-94.
53. Mohima T, Dewan I, Islam SM, Rana S, Hossain A. Encapsulation of zudividine in different cellulose acrylic and methaacrylic polymers loaded microspheres: In vitro characterization and compatability studies. Int J Pharm Pharm Sci 2015;7:487-95.
54. Osmani RA, Thirumaleshwar S, Bhosale RR, Kulkarni PK. Nanosponges: The spanking accession in drug delivery – An updated comprehensive review. Pelagia Res Lib Pharm Sin 2014;5:7-21.
55. Aggarwal G, Nagpal M, Kaur G. Development and comparison of nanosponge and niosome based gel for the topical delivery of tazarotene. Pharm Nanotechnol 2016;4:213-28.
56. Seema G, Kumar SA, Manoj B. Development and evaluation of curcumin loaded nanosponges for colon drug delivery. World J Pharm Res 2015;4:1650-66.
57. Rajeswari C, Alka A, Javed A, Khar RK. Cyclodextrins in drug delivery: An update review. AAPS Pharm Sci Tech 2005;6:E329-57.
58. Morsi N, Ghorab D, Refai H, Teba H. Preparation and evaluation of alginate/chitosan nanosdispersion for occular delivery. Int J Pharm Pharm Sci 2015;7:234-40.
59. Patel EK, Oswal RJ. Nanosponge and microsponges: A novel drug delivery system. Int J Res Pharm Chem 2012;2:237-44.
60. Singh R, Bharti N, Madan J, Hiremath SN. Characterization of cyclodextrin inclusion complexes – A review. J Pharm Sci Technol 2010;2:171-83.
61. Shankar S, Linda P, Loredana S, Francesco T, Pradeep V, Dino A, et al. Cyclodextrin based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity. Eur J Pharm Biopharm 2010;74:193-1.
62. Richhariya N, Prajapati SK, Sharma UK. Nanosponges: An innovative drug delivery system. World J Pharm Res 2015;4:1747-59.
63. Shivani S, Poladi KK. Nanosponges – Novel emerging drug delivery system: A review. Int J Pharm Sci Res 2015;6:529-40.
64. Ajinkya K, Prakash K, Vishal P. Scaffold based drug delivery system: A special emphasis on nanosponges. Int J Pharm Drug Anal 2015;4:98 104.
65. Ajinkya K, Prakash K, Vishal P. Scaffold based drug delivery system: A special emphasis on nanosponges. Int J Pharm Drug Anal 2015;4:98 104.
66. Qurat-Ul-Ain Shoaib, Abbas N, Irfan M, Hussain A, Arshad MS, Latif S, et al. Development and evaluation of scaffold-based nanosponge formulation for controlled drug delivery of naproxen and Ibuprofen. Trop J Pharm Res 2018;17:1465-74.
67. Patel B, Bagade O, Ramteke K, Patel R, Awsarkar V. An assessment on preparations, characterization, and poles a part appliances of nanosponge. Int J PharmTech Res 2014;6:2092-1.
68. Subhash PB, Mohite SK. Formulation design and development of artesunate nanosponge. Eur J Pharm Med Res 2016;3:206-11.
69. Raja CH, Kumar GK, Anusha K. Fabrication and evaluation of ciprofloxacin loaded nanosponges for sustained release. Int J Res Pharm Nano Sci 2013;2:1-9.
70. Rao MR, Bajaj AN, Pardeshi AA, Aghav SS. Investigation of nanoporous colloidal carrier for solubility enhancement of cefpodoxime proxetil. J Pharm Res 2012;5:2496-9.
71. Arvapalli S, Khan I, Sharma JV, Shyamala. Formulation and in vitro evaluation of ?-cyclodextrin based nanosponges. Sch Acad J Pharm 2017;6:175-85.
72. Srinivas P, Reddy AJ. Formulation and evaluation of isoniazid loaded nanosponges for topical delivery. Pharm Nanotechnol 2015;3:68-76.
73. Tejashri G, Amrita B, Darshana J. Cyclodextrin based nanosponges for pharmaceutical use: A review. Acta Pharm 2013;63:335-58.
74. Chilajwar SV, Pednekar PP, Jadhav KR, Gupta GJ, Kadam VJ. Cyclodextrin-based nanosponges: A propitious platform for enhancing drug delivery. Expert Opin Drug Deliv 2014;11:111-20.
75. Manyam N, Reddy Budideti KK, Mogili S. Formulation and in vitro evaluation of nanosponges loaded extended release tablets of Trimethoprim. Unique Pub J Pharm Med Health Sci 2018;1:78-86.
76. Bhownik H, Nagasamy Venkatesh D, Kuila A, Kumar KH. Nanospomges: A review. Int J Appl Pharm 2018;10:1-5.
77. Mathew F, Nair SS, Nair KG, Soman A, Alias M, Joseph J, Varghese N. A review on targeted drug delivery through nanosponge. Int J Univ Pharm BioSci 2014;3:377-91.
78. Khalid AA, Pradeep RV, Francesco T, Roberta C. Cyclodextrin based nanosponges for delivery of Resveratrol: In vitro characterisation, stability, cytotoxicity and permeation study. AAPS Pharm Sci Tech 2011;12:279-86.
79. Indira B, Bolisetti SS, Samrat C, Reddy SM, Reddy NS. Nanosponges: A new era in drug delivery: Review. J Pharm Res 2012;5:5293-6.
80. Cavalli R, Trotta F, Tumiatti W. Cyclodextrin-based nanosponges for drug delivery. J Incl Phenom Macro Chem 2012;56:209-13.
81. Torne S, Darandale S, Vavia P, Trotta F, Cavalli R. Cyclodextrin based nanosponges: Effective nanocarrier for tamoxifen delivery. Pharm Dev Technol 2013;18:619-25.
82. Swaminathan S, Vavia PR, Trotta F, Torne S. Formulation of betacyclodextrin based nanosponges of itraconazole. J Incl Phenom Macrcycl Chem 2007;57:89-94.
83. Deshpande A, Patel P. Preparation and evaluation of cyclodextrin based atorvastatin nanosponges. Am J PharmTech Res 2014;4:2249-87.
84. Ansari KA, Torne SJ, Vavia PR, Trotta F, Cavalli R. Paclitaxel loaded nanosponges: In vitro characterization and cytotoxicity study on MCF- 7 cell line culture. Curr Drug Deliv 2011;8:194-202.
85. Ansari KA, Vavia PR, Cavalli R. Cyclodextrin based nanosponges for delivery of resveratrol: In vitro characterisation, stability, cytotoxicity and permeation study. AAPS Pharm Sci Tech 2011;12:279-86.
86. Darandale SS, Vavia PR. Cyclodextrin-based nanosponges of curcumin: Formulation and physicochemical characterization. J Incl Phenom Macrocycl Chem 2013;75:315-22.
87. Shende PK, Trotta F, Gaud RS, Deshmukh K, Cavalli R, Biasizzo M. Influence of different techniques on formulation and comparative characterization of inclusion complexes of ASA with ?-cyclodextrin and inclusion complexes of ASA with PMDA cross-linked ?-cyclodextrin nanosponges. J Incl Phenom Macrocycl Chem 2012;74:447-54.
88. Trotta F, Cavalli R, Vavia PR, Khalid A. Cyclodextrin nanosponges as effective gas carriers. J Incl Phenom Macrocycl Chem 2011. DOI: 10.1007/s10847-011-9926-5.
89. Che-Ming JH, Fang RH, Copp J, Luk BT, Zhang L. A biomimetic nanosponges that absorbs poreforming toxins. Nat Nanotechnol 2013;8:336-40.
90. Shringirishi M, Mahor A, Gupta R, Prajapati SK, Bansal K, Kesharwani P. Fabrication and characterization of nifedipine loaded ? cyclodextrin nanosponges: An in vitro and in vivo evaluation. J Drug Deliv Sci Technol 2017;41:344-50.
91. Martin A, Swarbrick J, Cammarrata A. Physical Pharmacy: Physical Chemical Principles in Pharmaceutical Sciences. Vol. 3. Philadelphia, PA: Lea and Febiger; 1991. p. 527.
92. Shankar G, Agarwal YK. Formulation and evaluation of beta cyclodextrin based nanosponges of a poorly water soluble drug. J Chem Pharm Res 2015;7:595-604.
93. Rao MR, Chaudhari J, Trotta F, Caldera F. Investigation of cyclodextrin-based nanosponges for solubility and bioavailability enhancement of rilpivirine. AAPS PharmSciTech 2018;19:2358-69.
94. Amber V, Shailendra S, Swarnalatha S. Cyclodextrin based novel drug delivery systems. J Incl Phenom Macrocycl Chem 2008;62:23-42.
95. Cavalli R, Trotta F, Tumiatti W, Serpe L, Zara G. P.5-Fluorouracile Loaded ?-cyclodextrin Nanosponges: In vitro Characterization and Cytotoxicity. Turin, Italy: Proceedings XIII International Cyclodextrin Symposium; 2006. p. 207.
96. Sapino S, Carlotti R, Ugazio E, Berlie G, Gastaldi L. Photochemical and antioxidant properties of gammaoryzanol in beta-cyclodextrin based nanosponges. J Incl Phenom Macrocyl Chem 2013;75:69-76.
97. Emanuele AD, Dinarvand R. Preparation, characterization and drug release from thermo responsive microspheres. Int J Pharm 1995;45:237 42.
98. Silpa JN, Nissankararao S, Bhimavarapu R, Sravanthi SL, Vinusha K, Renuka K. Nanosponges: A versatile drug delivery system. Int J Pharm Life Sci 2013;4:2920-5.
99. Kumar PS, Hematheerthani N, Ratna JV, Saikishore V. Design and characterization of miconazole nitrate loaded nanosponges containing vaginal gels. Int J Pharm Anal Res 2016;5:410-7.
100. Srinivas P, Reddy AJ. Formulation and evaluation of isoniazid loaded nanosponges for topical delivery. Pharm Nanotechnol 2015;3:68-76.
101. Jilsha G, Viswanad V. Nanosponges loaded hydrogel of cephalexin for topical delivery. Int J Pharm Sci Res 2015;6:2781-9.
102. Trotta F, Tumiatti W, Orfbinati, Roggero C, Vallero R. Ultrasound – assisted Cyclodextrin based nanosponges.
103. Universita Deglistudi , Di Torino, Sea Marconi, Technologies Di , Method of preparing dextrin nanosponges.
104. Gilardi G, Cavalli F, Ferutti P, Ranucci E, Nardo G, Roggero CM, et al. Cyclodextrin nanosponges as a carrier for biocatalyst, and in the delivery and release of enzymes, proteins, vaccines and antibodies.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.